NeuroVive Pharmaceutical AB publishes 2018 Annual report
Lund, Sweden, 25 March 2019, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2018 is now available on the company’s website www.neurovive.com.This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 10:00 a.m. CET on 25 March 2019. For more information please contact:Catharina Johansson, CFO, IR & Communications+46 (0)